Want to see NXPL full AI Analyst Report?
Top Page
NextPlat
(NASDAQ:NXPL)
Select Model
Select Model
Rating:55Neutral
Price Target:
$9.50
▲(61.84% Upside)
Action:Reiterated
Date:08/18/26
NXPL scores as a mixed setup: the largest drag is weak financial performance driven by ongoing operating losses and negative free cash flow, despite low leverage. Offsetting this are strong technical momentum (price above key moving averages) and a constructive earnings call centered on margin expansion and sharply reduced operating losses, though revenue declines and dilution/legal overhangs temper the outlook. Valuation provides limited support due to negative earnings and no indicated dividend yield.
Positive Factors
Margin Expansion
The sharp margin improvement indicates better revenue quality, pricing, or operating mix. If sustained, higher gross profit per dollar of revenue can support continued loss reduction and improve the company’s path toward durable profitability.
Negative Factors
Persistent Cash Burn
Ongoing operating and free-cash-flow losses mean the business is not yet self-funding. Continued cash burn could consume liquidity, limit investment capacity, and eventually require external financing if profitability does not improve as planned.
Read all positive and negative factors
Positive Factors
Negative Factors
Margin Expansion
The sharp margin improvement indicates better revenue quality, pricing, or operating mix. If sustained, higher gross profit per dollar of revenue can support continued loss reduction and improve the company’s path toward durable profitability.
Read all positive factors
NextPlat (NXPL) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$25.26M
Dividend YieldN/A
Average Volume (3M)307.20K
Price to Earnings (P/E)―
Beta (1Y)1.05
Revenue Growth-17.82%
EPS Growth19.42%
CountryUS
Employees126
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)-3.81
Shares Outstanding2,713,222
10 Day Avg. Volume353,303
30 Day Avg. Volume307,201
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)0.80
Price to Sales (P/S)0.26
P/FCF Ratio-2.24
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$11.00Price Target Upside87.39% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.55
Revenue Forecast (FY)$48.85M
NextPlat Business Overview & Revenue Model
Company Description
NextPlat Corp, along with its subsidiaries, specializes in providing advanced mobile satellite services (MSS). These offerings encompass satellite-enabled voice and data communication, comprehensive personnel and asset tracking, machine-to-machine...
How the Company Makes Money
NextPlat primarily makes money through (1) product revenue from e-commerce sales and (2) service and product revenue from its healthcare/pharmacy operations. In e-commerce, revenue is generated when the company sells products to customers through ...
NextPlat Earnings Call Summary
Earnings Call Date:May 14, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Nov 16, 2026
Earnings Call Sentiment Positive
The call communicates a clear and measurable operational turnaround: substantial margin expansion, sharply reduced operating losses, the healthcare segment returning to profitability, growth in higher-margin pharmacy contract revenue, and stabilized e-commerce performance. These positive developments are counterbalanced by meaningful declines in top-line revenue (both YoY and sequential), an ongoing legal matter, prior Nasdaq compliance actions (reverse split) and the potential dilution implied by an ATM facility. On balance, the improvements in profitability, margins, and segment-level performance are material and portrayed as sustainable catalysts for future growth, outweighing the remaining revenue and corporate governance headwinds.Positive Updates
Significant Gross Margin Expansion
Consolidated gross margin expanded to approximately 35% in Q1 2026, up from ~21% in Q1 2025 (+14 percentage points YoY) and up from ~18% in Q4 2025 (+17 percentage points sequential). Consolidated gross profit rose to ~$3.4M (from ~$2.9M YoY, +17.2%).
Negative Updates
Total Revenue Decline YoY and Sequential
Total net revenues were approximately $10M in Q1 2026, down from ~$14M in the prior year period (-~28.6% YoY) and down from ~$13M in Q4 2025 (-~23.1% sequential), reflecting the effects of prior restructuring and shifting revenue mix.
Read all updates
Q1-2026 Updates
Positive
Negative
Significant Gross Margin Expansion
Consolidated gross margin expanded to approximately 35% in Q1 2026, up from ~21% in Q1 2025 (+14 percentage points YoY) and up from ~18% in Q4 2025 (+17 percentage points sequential). Consolidated gross profit rose to ~$3.4M (from ~$2.9M YoY, +17.2%).
Read all positive updates
Company Guidance
Guidance: management expects operational profitability in the latter half of 2026 with meaningful reductions in operating losses in H2 as new higher‑margin 340B and medication‑fulfillment customers ramp (the company signed five new 340B agreements this quarter that require ~90 days to onboard and are expected to contribute in Q3) and a new e‑commerce healthcare site is slated to go live before the end of Q2. Key metrics supporting that guidance: Q1 net revenues ≈ $10.0M (healthcare ≈ $7.0M, e‑commerce ≈ $3.2M; healthcare ≈ 68% of revenue), pharmacy contract revenue ≈ $1.9M (vs $1.6M in Q4’25 and $1.4M year‑ago), average 7,500 prescriptions filled/month to Florida contract facilities, consolidated gross profit ≈ $3.4M and gross margin ≈ 35% (vs ~21% in Q1’25 and ~18% in Q4’25), pharmacy gross margin ≈ 39% (vs ~20% prior year), total operating expenses ≈ $4.5M (salaries ≈ $2.4M), operating loss ≈ $1.1M (improved from ~$2.1M year‑ago and ~$2.8M Q4’25), cash ≈ $11M and working capital ≈ $14M; management also cited nationwide expansion to all 50 states, record IoT/e‑commerce demand across 130+ countries, and an ATM facility in place for optional capital although there are no current plans to access it.NextPlat Financial Statement Overview
Summary
Income Statement
26
Negative
Balance Sheet
58
Neutral
Cash Flow
22
Negative
| Breakdown | TTM | Mar 2026 | Dec 2024 | Mar 2024 | Mar 2023 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.29M | 54.32M | 65.48M | 37.76M | 11.71M | 7.74M |
| Gross Profit | 12.67M | 10.91M | 16.23M | 11.31M | 2.49M | 1.86M |
| EBITDA | -8.48M | -9.86M | -20.15M | -19.68M | -6.71M | -6.29M |
| Net Income | -9.84M | -11.71M | -14.03M | -3.78M | -9.16M | -8.11M |
Balance Sheet | ||||||
| Total Assets | 28.67M | 27.46M | 36.48M | 64.47M | 28.64M | 20.57M |
| Cash, Cash Equivalents and Short-Term Investments | 11.94M | 13.71M | 19.96M | 26.31M | 18.89M | 17.27M |
| Total Debt | 1.58M | 1.49M | 2.26M | 3.01M | 1.07M | 365.22K |
| Total Liabilities | 12.19M | 10.04M | 9.68M | 16.38M | 2.87M | 3.03M |
| Stockholders Equity | 16.39M | 17.31M | 26.68M | 0.00 | 25.78M | 17.53M |
Cash Flow | ||||||
| Free Cash Flow | -4.57M | -6.20M | -5.65M | -4.24M | -4.32M | -4.32M |
| Operating Cash Flow | -4.53M | -6.13M | -5.46M | -3.60M | -3.60M | -4.09M |
| Investing Cash Flow | 65.00K | 163.00K | -953.00K | 5.20M | -7.72M | -229.31K |
| Financing Cash Flow | -252.00K | -225.00K | 72.00K | 5.86M | 13.01M | 20.82M |
NextPlat Technical Analysis
Positive
5.87
Price Trends
6.81
Positive
6.52
Positive
6.20
Positive
Market Momentum
0.76
Negative
76.81
Negative
84.22
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NXPL, the sentiment is Positive. The current price of 5.87 is below the 20-day moving average (MA) of 7.47, below the 50-day MA of 6.81, and below the 200-day MA of 6.20, indicating a bullish trend. The MACD of 0.76 indicates Negative momentum. The RSI at 76.81 is Negative, neither overbought nor oversold. The STOCH value of 84.22 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NXPL.
NextPlat Risk Analysis
NextPlat disclosed 28 risk factors in its most recent earnings report. NextPlat reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
NextPlat Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | $25.26M | -2.45 | -58.38% | ― | -17.82% | 19.42% | |
51 Neutral | $16.35M | -2.35 | -18.44% | ― | ― | ― | |
50 Neutral | $9.19M | -0.12 | -135.04% | ― | -20.40% | 32.15% | |
50 Neutral | $108.91M | -1.09 | -164.91% | ― | 43.04% | 59.79% | |
39 Underperform | $3.11M | -0.08 | -228.97% | ― | 25.23% | -144.16% |
* Technology Sector Average
NXPL
NextPlat
9.32
1.92
25.88%
IPM
Intelligent Protection Management
1.86
-0.09
-4.62%
CXAI
CXApp
3.96
-35.91
-90.07%
RYDE
Ryde Group Limited Class A
0.64
0.34
114.00%
WCT
Wellchange Holdings Company Limited
0.75
-9.73
-92.85%
NTCL
NetClass Technology Inc Class A
2.42
-84.58
-97.22%
NextPlat Corporate Events
Executive/Board ChangesShareholder Meetings
NextPlat Shareholders Reaffirm Board and Governance Structure
Positive
Jun 24, 2026
On June 24, 2026, NextPlat Corp held its 2026 Annual Meeting, with approximately 62.23% of outstanding common shares represented, and shareholders elected six board nominees, including Chairman Rodney Barreto and Vice-Chairman Douglas S. Ellenoff,...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.